Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06365047 · ClinicalTrials.gov registry record · Phase 3
Dry Mouth Toothpaste Study - Comparing Two Toothpastes With Arginine
A Phase 3 study of Xerostomia, sponsored by Tufts University.
- Active
- Registry status
- Phase 3
- Development phase
- 70
- Enrollment target
- 1
- Study location
NCT06365047 is a Phase 3 study of Xerostomia that is active but no longer recruiting, run by Tufts University. The registered enrollment target is 70 participants, below the 90-participant average among 13 other Xerostomia trials with a reported enrollment target (22% lower). The trial reports 1 study location across 1 state.
The verdict
NCT06365047, a Phase 3 study of Xerostomia, is active but no longer recruiting, sponsored by Tufts University.
- ACTIVE NOT RECRUITING
- Registry status
- Phase 3
- Development phase
- 70 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a clinical investigation to measure the changes in the oral environment resulting from a 3 month exposure to an arginine containing toothpaste. This study is a double blind, randomized controlled, parallel design. Seventy (70) male and female subjects who meet the inclusion/exclusion criteria will be enrolled in the study. Following oral health evaluations, subjects will be assigned to the treatment schedule and receive their assigned study product.
Conditions Studied
Interventions
- DEVICE 8% Arginine toothpaste
- DRUG 1000 ppm F toothpaste
Study Locations (1)
Massachusetts
- Tufts University School of Dental Medicine - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 70 participants |
| Start Date | 2024-08-31 |
| Est. Completion | 2028-06-01 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06365047
The ClinicalTrials.gov registry entry for NCT06365047 describes a study currently listed as active not recruiting, categorized as Phase 3. The registered enrollment target is 70 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 90-participant average among 13 other Xerostomia trials with a reported enrollment target (22% lower). The listed sponsor is Tufts University, which has 163 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Xerostomia appearing as the primary indexed condition, and to 2 interventions - of which 8% Arginine toothpaste is the first listed.
NCT06365047 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.
Frequently Asked Questions
What is clinical trial NCT06365047 about?
NCT06365047 is a clinical study titled "Dry Mouth Toothpaste Study - Comparing Two Toothpastes With Arginine". This is a clinical investigation to measure the changes in the oral environment resulting from a 3 month exposure to an arginine containing toothpaste. This study is a double blind, randomized controlled, parallel design. Seventy (70) male and female subjects who meet the inclusion/exclusion criteri...
What is the current status of trial NCT06365047?
This trial is currently active not recruiting. It is a Phase 3 study. The enrollment target is 70 participants. The study started on 2024-08-31. Estimated completion is 2028-06-01.
What conditions does trial NCT06365047 study?
This clinical trial studies the following conditions: Xerostomia.
What interventions are being tested in trial NCT06365047?
The interventions under investigation include: 8% Arginine toothpaste (DEVICE), 1000 ppm F toothpaste (DRUG).
Who is sponsoring clinical trial NCT06365047?
This trial is sponsored by Tufts University, which has 163 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06365047 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Xerostomia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
d-Limonene +Radiation +PlatinumBasedChemo for Xerostomia Prevention in LocallyAdvanced HNSCC
RECRUITING · Phase 1
-
Dose-Escalation Trial of Mesenchymal Stromal Cells in Patients With Medical Xerostomia
RECRUITING · Phase 1
-
Study Transplanting Bone Marrow Cells Into Salivary Glands to Treat Dry Mouth Caused by Radiation Therapy
ACTIVE NOT RECRUITING · Phase 1
-
Effect of Whitening Agent With Emulsion Gel in Saliva and Halitosis
ACTIVE NOT RECRUITING · NA
-
Observational Study of Dental Outcomes in Head and Neck Cancer Patients
ACTIVE NOT RECRUITING
-
Effect of Childhood Radioiodine Therapy on Salivary Function
COMPLETED
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.